Benign Prostate Hyperplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria for BPH in the *Chinese Guidelines for the Diagnosis and Treatment of Urological and Andrological Diseases: 2022 Edition*, confirmed by comprehensive evaluations including imaging and digital rectal examination. 2. Clear surgical indications are present (patients with moderate-to-severe LUTS who have inadequate response to or refuse medical therapy, or those with BPH-related complications: (1) recurrent urinary retention; (2) recurrent urinary tract infections; (3) bladder stones or bladder diverticula; (4) recurrent gross hematuria; (5) overflow incontinence and/or secondary upper urinary tract dilation). 3. Preoperative anesthetic assessment confirms suitability for anesthesia (ASA physical status classification I–II).
Exclusion criteria
Exclusion criteria: 1. Patients with abnormally elevated PSA levels in whom prostate cancer cannot be excluded. 2. Patients with severe urinary tract infections. 3. Patients with an acontractile bladder or neurogenic bladder dysfunction. 4. Patients with severe cardiopulmonary diseases, classified as ASA physical status grade III–IV. 5. Patients with diabetes mellitus and poor glycemic control. 6. Patients unwilling to participate in the clinical study protocol. 7. Any other conditions deemed unsuitable for participation in the study by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ambulatory-surgery completion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score;Quality of life score;Maximum urine flow rate;residual urine volume;surgical expense;Surgical time; | — |
Countries
China
Contacts
First Affiliated Hospital of Army Medical University, Chinese People's Liberation Army